ケース スタディ

Since 2014, our customers have received over 90% of new drug and biologic approvals by the FDA. These FDA approvals span across several designations and therapeutic areas, including oncology, infectious disease, hematology, pulmonology, cardiology, dermatology, diabetes, neurology, gastroenterology, psychiatry, bone, migraine, sleep disorders and more. View the case studies below to see for yourself.